Cognoa preps FDA filing for digital autism diagnostic
pharmaphorum
SEPTEMBER 24, 2020
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. Cognoa has revealed however that the trial suggests the app is highly accurate across males and females as well as ethnic and racial backgrounds.
Let's personalize your content